Header Logo

Connection

RIMA M SALIBA to Antigens, CD20

Back to Details
This is a "connection" page, showing publications RIMA M SALIBA has written about Antigens, CD20.
RIMA M SALIBA
Connection Strength
0.016
Antigens, CD20
  1. High-dose rituximab does not negatively affect peripheral blood stem cell mobilization kinetics in patients with intermediate-grade non-Hodgkin's lymphoma. Leuk Lymphoma. 2006 Jul; 47(7):1290-4.
    View in: PubMed
    Score: 0.016
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.